Axonics, Inc. (AXNX) Tops Q3 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LRCX
7. MRK
8. LVS
9. SAP
10. CSX

Go back to Axonics, Inc. (AXNX) Tops Q3 EPS by 13c

Axonics Reports Third Quarter 2023 Financial Results

October 30, 2023 4:01 PM EDT

Generated quarterly revenue of $93.1 million, an increase of 32% year over year

Fiscal year 2023 revenue guidance increased to $362 million

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the three months ended September 30, 2023.

Our commercial team continues to execute at a high level, generating over 30% revenue growth in the third quarter, said Raymond W. Cohen, chief executive officer. Our... More